CYP2D6 and breast cancer: The third potential explanation for the mixed results on poor CYP2D6 metabolism is the use of DNA from different sources in different studies.39 Two trials have previously reported a null association between poor CYP2D6 metabolism and breast cancer outcomes.8,9 However, the validity of the two studies has been questioned because those trials used tumor DNA.39